"2005-06-10T12:07:02+02:00"^^ . . . "MJE" . "The reason why the Duty is necessary for the Responsible_party. Rigorous posttreatment follow-up is mandatory, because long-term recurrence rates after treatment of melanoma in situ with imiquimod are yet unknown."@en . "Extra-Thematic"^^ . "Extra-Thematic" . . . . "8147"^^ . "The reason why the Duty is necessary for the Responsible_party. \nRigorous posttreatment follow-up is mandatory, because long-term recurrence rates after treatment of melanoma in situ with imiquimod are yet unknown. \n"^^ . . . "Explanation" . "The reason why the Duty is necessary for the Responsible_party. Rigorous posttreatment follow-up is mandatory, because long-term recurrence rates after treatment of melanoma in situ with imiquimod are yet unknown."@en . "exp" . "Explanation" . "Explanation"^^ . .